In contrast, Erbb4-IR is another novel Smad3-dependent lncRNA capable of inhibiting renal fibrosis by targeting miR-29b and Smad7 in both obstructive nephropathy and type II diabetic nephropathy, respectively (Feng et al., 2018; Sun et al., 2018). The gene discussed is SMAD7; the disease is renal fibrosis.